NARB Tells Origins To Drop Comparison To Rx Anti-Wrinkle Products
This article was originally published in The Rose Sheet
The National Advertising Review Board upholds a NAD ruling that the brand should discontinue claims comparing its Plantscription anti-aging serum to anti-wrinkle prescription products. NARB reversed several other NAD decisions on certain claims for the same product.
You may also be interested in...
The Estee Lauder Companies’ Origins unit is appealing to NARB after NAD advised the firm to drop or modify claims comparing its Plantscription products to anti-aging prescription cream Renova.
Performance claims from University Medical Pharmaceuticals touting the quick-acting effect of its WrinkleFree Eyes and comparing the product to Botox should be discontinued, the National Advertising Division says
A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.